Tekla Capital Management is an investment fund managing more than $2.56 trillion ran by Laura Woodward. There are currently 166 companies in Mrs. Woodward’s portfolio. The largest investments include AMGEN and Johnson & Johnson, together worth $256 billion.
As of 3rd August 2023, Tekla Capital Management’s top holding is 616,539 shares of AMGEN currently worth over $137 billion and making up 5.4% of the portfolio value.
Relative to the number of outstanding shares of AMGEN, Tekla Capital Management owns more than approximately 0.1% of the company.
In addition, the fund holds 721,779 shares of Johnson & Johnson worth $119 billion, whose value grew 6.7% in the past six months.
The third-largest holding is Gilead Sciences worth $118 billion and the next is Regeneron Pharmaceuticals worth $116 billion, with 161,418 shares owned.
Currently, Tekla Capital Management's portfolio is worth at least $2.56 trillion. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Tekla Capital Management office and employees reside in Boston, Massachusetts. According to the last 13-F report filed with the SEC, Laura Woodward serves as the Chief Compliance Officer at Tekla Capital Management.
In the most recent 13F filing, Tekla Capital Management revealed that it had opened a new position in
Insulet and bought 43,847 shares worth $12.6 billion.
This means they effectively own approximately 0.1% of the company.
Insulet makes up
0.6%
of the fund's Health Care sector allocation and has decreased its share price by 12.5% in the past year.
The investment fund also strengthened its position in AMGEN by buying
60,600 additional shares.
This makes their stake in AMGEN total 616,539 shares worth $137 billion.
AMGEN soared 3.5% in the past year.
On the other hand, there are companies that Tekla Capital Management is getting rid of from its portfolio.
Tekla Capital Management closed its position in Travere Therapeutics, Inc. on 10th August 2023.
It sold the previously owned 418,520 shares for $9.41 billion.
Laura Woodward also disclosed a decreased stake in Gilead Sciences by approximately 0.1%.
This leaves the value of the investment at $118 billion and 1,533,884 shares.
The two most similar investment funds to Tekla Capital Management are Ergoteles and Nicholas Hoffman ,. They manage $2.56 trillion and $2.56 trillion respectively.
Tekla Capital Management’s portfolio is diversified across 5 sectors.
Currently, their heaviest sector is Health Care — making up 87.2% of
the total portfolio value.
The fund focuses on investments in the United States as
70.5% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are large-cap stocks.
Stocks with a size of more than $10 billion in market cap make up
36% of the total holdings value.
On the other hand, small-cap stocks make up only 5.4% of the portfolio.
The average market cap of the portfolio companies is close to $38.1 billion.
These positions were updated on August 10th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| AMGEN Inc. |
10.90%
616,539
|
$136,883,989,000 | 5.36% |
| Johnson & Johnson |
No change
721,779
|
$119,468,860,000 | 4.68% |
| Gilead Sciences, Inc. |
1.67%
1,533,884
|
$118,216,440,000 | 4.63% |
| Regeneron Pharmaceuticals, Inc. |
12.84%
161,418
|
$115,985,290,000 | 4.54% |
| Vertex Pharmaceuticals, Inc. |
3.72%
318,043
|
$111,922,512,000 | 4.38% |
| Eli Lilly And Company |
26.15%
213,352
|
$100,057,821,000 | 3.92% |
| Unitedhealth Group Inc |
11.62%
206,961
|
$99,473,735,000 | 3.89% |
| Merck & Co Inc |
31.88%
728,154
|
$84,021,690,000 | 3.29% |
| Abbvie Inc |
6.65%
545,629
|
$73,512,595,000 | 2.88% |
| Biogen Inc |
2.91%
247,943
|
$70,626,564,000 | 2.76% |
| Astrazeneca plc |
1.61%
976,676
|
$69,900,701,000 | 2.74% |
| Illumina Inc |
3.19%
336,979
|
$63,180,193,000 | 2.47% |
| Abbott Laboratories |
11.44%
552,455
|
$60,228,644,000 | 2.36% |
| Pfizer Inc. |
8.48%
1,624,476
|
$59,585,780,000 | 2.33% |
| Thermo Fisher Scientific Inc. |
5.64%
98,987
|
$51,646,467,000 | 2.02% |
| Elevance Health, Inc. |
No change
114,070
|
$50,680,160,000 | 1.98% |
| Moderna Inc |
6.67%
343,695
|
$41,758,943,000 | 1.63% |
| Boston Scientific Corp. |
16.22%
657,790
|
$35,579,861,000 | 1.39% |
| Danaher Corp. |
35.12%
142,813
|
$34,275,120,000 | 1.34% |
| Medtronic Plc |
0.03%
344,417
|
$30,343,138,000 | 1.19% |
| Idexx Laboratories, Inc. |
No change
58,595
|
$29,428,167,000 | 1.15% |
| Dexcom Inc |
No change
228,747
|
$29,396,277,000 | 1.15% |
| Bristol-Myers Squibb Co. |
30.93%
458,498
|
$29,320,947,000 | 1.15% |
| Intuitive Surgical Inc |
25.47%
83,980
|
$28,716,121,000 | 1.12% |
| Alnylam Pharmaceuticals Inc |
No change
143,214
|
$27,202,067,000 | 1.06% |
| Cigna Group (The) |
47.25%
96,339
|
$27,032,723,000 | 1.06% |
| Mckesson Corporation |
6.77%
61,955
|
$26,473,991,000 | 1.04% |
| Argenx Se |
25.77%
65,553
|
$25,547,971,000 | 1.00% |
| HCA Healthcare Inc |
7.10%
82,403
|
$25,007,662,000 | 0.98% |
| Stryker Corp. |
13.34%
81,128
|
$24,751,342,000 | 0.97% |
| IQVIA Holdings Inc |
72.90%
109,129
|
$24,528,925,000 | 0.96% |
| Zoetis Inc |
No change
136,914
|
$23,577,960,000 | 0.92% |
| Charles River Laboratories International Inc. |
5.84%
111,183
|
$23,376,226,000 | 0.91% |
| Seagen Inc |
50.00%
112,331
|
$21,619,224,000 | 0.85% |
| Sarepta Therapeutics Inc |
37.18%
179,437
|
$20,549,125,000 | 0.80% |
| Novo Nordisk A/s |
10.29%
122,777
|
$19,869,002,000 | 0.78% |
| Oculis Holding Ag |
No change
1,690,741
|
$18,823,020,000 | 0.74% |
| Molina Healthcare Inc |
No change
61,856
|
$18,633,501,000 | 0.73% |
| Jazz Pharmaceuticals plc |
No change
147,779
|
$18,320,163,000 | 0.72% |
| Biomarin Pharmaceutical Inc. |
29.76%
210,789
|
$18,271,191,000 | 0.72% |
| Edwards Lifesciences Corp |
10.78%
189,597
|
$17,884,685,000 | 0.70% |
| Humana Inc. |
No change
36,794
|
$16,451,701,000 | 0.64% |
| Apellis Pharmaceuticals Inc |
28.21%
173,248
|
$15,782,893,000 | 0.62% |
| Baxter International Inc. |
381.89%
324,370
|
$14,778,297,000 | 0.58% |
| Exelixis Inc |
No change
726,639
|
$13,886,071,000 | 0.54% |
| Novartis AG |
No change
136,225
|
$13,746,465,000 | 0.54% |
| Karuna Therapeutics Inc |
9.59%
58,577
|
$12,702,422,000 | 0.50% |
| Insulet Corporation |
Opened
43,847
|
$12,642,844,000 | 0.49% |
| Guardant Health Inc |
26.71%
346,084
|
$12,389,807,000 | 0.48% |
| Ascendis Pharma A/S |
12.12%
138,791
|
$12,387,097,000 | 0.48% |
| Spdr S&p Biotech Etf |
No change
147,677
|
$12,286,726,000 | 0.48% |
| Physicians Realty Trust |
No change
873,655
|
$12,222,433,000 | 0.48% |
| Tenet Healthcare Corp. |
Opened
149,070
|
$12,131,317,000 | 0.47% |
| BioNTech SE |
No change
103,858
|
$11,209,394,000 | 0.44% |
| Neurocrine Biosciences, Inc. |
No change
112,908
|
$10,647,224,000 | 0.42% |
| Zimmer Biomet Holdings Inc |
No change
67,356
|
$9,807,034,000 | 0.38% |
| Rallybio Corporation |
No change
1,727,067
|
$9,775,199,000 | 0.38% |
| Vaxcyte, Inc. |
3,784.64%
194,232
|
$9,699,946,000 | 0.38% |
| Alkermes plc |
No change
309,613
|
$9,690,887,000 | 0.38% |
| Denali Therapeutics Inc |
No change
324,829
|
$9,585,704,000 | 0.38% |
| Avantor, Inc. |
No change
459,488
|
$9,437,884,000 | 0.37% |
| Travere Therapeutics, Inc. |
Closed
418,520
|
$9,412,515,000 | |
| Omega Healthcare Investors, Inc. |
No change
306,433
|
$9,404,429,000 | 0.37% |
| Laboratory Corporation Of America Holdings |
Closed
40,042
|
$9,186,436,000 | |
| United Therapeutics Corp |
32.25%
41,465
|
$9,153,399,000 | 0.36% |
| Intra-Cellular Therapies Inc |
23.75%
131,435
|
$8,322,464,000 | 0.33% |
| Acadia Healthcare Company Inc |
45.89%
100,912
|
$8,036,632,000 | 0.31% |
| Madrigal Pharmaceuticals Inc |
175.89%
34,434
|
$7,954,254,000 | 0.31% |
| Resmed Inc. |
52.58%
34,704
|
$7,582,824,000 | 0.30% |
| Horizon Therapeutics Plc |
Opened
72,425
|
$7,448,911,000 | 0.29% |
| Inspire Medical Systems Inc |
Opened
22,018
|
$7,147,924,000 | 0.28% |
| Cytokinetics Inc |
No change
219,025
|
$7,144,596,000 | 0.28% |
| Steris Plc |
No change
31,072
|
$6,990,579,000 | 0.27% |
| Sanofi |
No change
123,454
|
$6,654,171,000 | 0.26% |
| R1 RCM Inc. |
No change
356,851
|
$6,583,901,000 | 0.26% |
| Lantheus Holdings Inc |
Closed
79,495
|
$6,563,107,000 | |
| CVS Health Corp |
No change
93,621
|
$6,472,020,000 | 0.25% |
| Medpace Holdings Inc |
185.30%
26,918
|
$6,464,896,000 | 0.25% |
| Immunovant Inc |
191.33%
336,200
|
$6,377,714,000 | 0.25% |
| Intellia Therapeutics Inc |
No change
154,269
|
$6,291,090,000 | 0.25% |
| LTC Properties, Inc. |
No change
182,293
|
$6,019,315,000 | 0.24% |
| Sabra Health Care Reit, Inc. |
No change
510,660
|
$6,010,468,000 | 0.24% |
| Vectivbio Holding Ag |
Closed
682,834
|
$5,872,372,000 | |
| Smith & Nephew plc |
No change
181,710
|
$5,860,148,000 | 0.23% |
| Chinook Therapeutics, Inc. |
80.67%
150,863
|
$5,796,156,000 | 0.23% |
| West Pharmaceutical Services, Inc. |
No change
15,036
|
$5,750,819,000 | 0.23% |
| Cerevel Therapeutics Holdings, Inc. |
No change
176,483
|
$5,610,395,000 | 0.22% |
| LivaNova PLC |
69.82%
108,480
|
$5,579,126,000 | 0.22% |
| Prometheus Biosciences, Inc. |
Closed
50,538
|
$5,423,738,000 | |
| Veradigm Inc |
No change
428,580
|
$5,400,108,000 | 0.21% |
| Agilent Technologies Inc. |
No change
43,191
|
$5,193,718,000 | 0.20% |
| Amedisys Inc. |
Closed
68,949
|
$5,071,199,000 | |
| Addus HomeCare Corporation |
Closed
42,380
|
$4,524,489,000 | |
| Marinus Pharmaceuticals Inc |
10.00%
411,101
|
$4,464,557,000 | 0.17% |
| uniQure N.V. |
45.39%
356,280
|
$4,082,969,000 | 0.16% |
| Amerisourcebergen Corp. |
No change
20,417
|
$3,928,843,000 | 0.15% |
| Medical Properties Trust Inc |
No change
411,743
|
$3,812,740,000 | 0.15% |
| BeiGene Ltd |
No change
20,952
|
$3,735,742,000 | 0.15% |
| Ionis Pharmaceuticals Inc |
No change
87,840
|
$3,604,075,000 | 0.14% |
| Biocryst Pharmaceuticals Inc. |
No change
504,528
|
$3,551,877,000 | 0.14% |
| Reata Pharmaceuticals, Inc. Class A |
91.88%
34,250
|
$3,492,130,000 | 0.14% |
| Cardiovascular Systems Inc. |
Closed
174,859
|
$3,472,700,000 | |
| Kura Oncology Inc |
Closed
283,281
|
$3,464,527,000 | |
| Teva- Pharmaceutical Industries Ltd. |
No change
459,651
|
$3,461,172,000 | 0.14% |
| Welltower Inc. |
No change
41,484
|
$3,355,641,000 | 0.13% |
| Healthcare Realty Trust Inc |
No change
174,686
|
$3,294,578,000 | 0.13% |
| Catalent Inc. |
Closed
49,406
|
$3,246,468,000 | |
| Ventas Inc |
No change
66,681
|
$3,152,011,000 | 0.12% |
| Ishares Biothechnology Etf |
No change
24,569
|
$3,119,280,000 | 0.12% |
| Blueprint Medicines Corp |
Closed
67,710
|
$3,046,273,000 | |
| Healthpeak Properties Inc. |
No change
150,392
|
$3,022,879,000 | 0.12% |
| Akero Therapeutics Inc |
Opened
61,497
|
$2,871,295,000 | 0.11% |
| Adaptive Biotechnologies Corporation |
No change
422,281
|
$2,833,506,000 | 0.11% |
| Galera Therapeutics Inc |
No change
898,374
|
$2,802,927,000 | 0.11% |
| Ultragenyx Pharmaceutical Inc. |
Closed
67,065
|
$2,689,307,000 | |
| Xenon Pharmaceuticals Inc |
19.36%
67,506
|
$2,598,981,000 | 0.10% |
| BridgeBio Pharma Inc |
No change
150,921
|
$2,595,841,000 | 0.10% |
| Arrowhead Pharmaceuticals Inc. |
Closed
100,422
|
$2,550,719,000 | |
| Koninklijke Philips N.V. |
4.46%
114,765
|
$2,489,253,000 | 0.10% |
| Syndax Pharmaceuticals Inc |
Closed
117,717
|
$2,486,183,000 | |
| Caribou Biosciences, Inc. |
No change
567,147
|
$2,410,375,000 | 0.09% |
| Mirati Therapeutics Inc |
No change
65,490
|
$2,366,154,000 | 0.09% |
| Icon Plc |
No change
9,334
|
$2,335,367,000 | 0.09% |
| Align Technology, Inc. |
Closed
6,925
|
$2,313,920,000 | |
| Amylyx Pharmaceuticals, Inc. |
Opened
104,007
|
$2,243,431,000 | 0.09% |
| Assertio Holdings, Inc. |
No change
410,575
|
$2,225,317,000 | 0.09% |
| Option Care Health, Inc. |
Closed
64,975
|
$2,064,256,000 | |
| Mereo BioPharma Group plc |
No change
1,551,082
|
$2,047,428,000 | 0.08% |
| 89bio Inc |
No change
105,898
|
$2,006,767,000 | 0.08% |
| Ardelyx Inc |
No change
539,408
|
$1,828,593,000 | 0.07% |
| Pyxis Oncology, Inc. |
No change
708,303
|
$1,813,256,000 | 0.07% |
| Perrigo Company plc |
No change
51,224
|
$1,739,055,000 | 0.07% |
| Takeda Pharmaceutical Co |
No change
105,073
|
$1,650,697,000 | 0.06% |
| Global Medical REIT Inc |
No change
174,897
|
$1,596,810,000 | 0.06% |
| GSK Plc |
No change
41,852
|
$1,491,605,000 | 0.06% |
| Tactile Systems Technology Inc |
69.82%
58,472
|
$1,457,707,000 | 0.06% |
| Arcutis Biotherapeutics Inc |
No change
148,874
|
$1,418,769,000 | 0.06% |
| Xencor Inc |
Opened
56,675
|
$1,415,175,000 | 0.06% |
| Crinetics Pharmaceuticals Inc |
No change
78,529
|
$1,415,093,000 | 0.06% |
| Morphosys AG |
116.44%
177,191
|
$1,323,617,000 | 0.05% |
| Merus N.V |
Closed
69,025
|
$1,270,060,000 | |
| CRISPR Therapeutics AG |
59.02%
22,571
|
$1,267,136,000 | 0.05% |
| Natera Inc |
50.00%
24,636
|
$1,198,788,000 | 0.05% |
| Edgewise Therapeutics, Inc. |
22.87%
150,418
|
$1,165,740,000 | 0.05% |
| Zai Lab Ltd. |
Closed
34,640
|
$1,152,126,000 | |
| Zentalis Pharmaceuticals, Llc |
Opened
40,156
|
$1,132,801,000 | 0.04% |
| Bicycle Therapeutics plc |
50.00%
44,338
|
$1,131,506,000 | 0.04% |
| G1 Therapeutics Inc |
No change
423,869
|
$1,055,434,000 | 0.04% |
| Fulcrum Therapeutics Inc |
338.85%
256,888
|
$847,730,000 | 0.03% |
| Scholar Rock Holding Corp |
No change
108,833
|
$820,601,000 | 0.03% |
| Diversified Healthcare Trust |
No change
357,720
|
$804,870,000 | 0.03% |
| Theseus Pharmaceuticals, Inc. |
No change
75,000
|
$699,750,000 | 0.03% |
| Mersana Therapeutics Inc |
Closed
162,383
|
$667,394,000 | |
| Arcus Biosciences Inc |
No change
32,839
|
$666,960,000 | 0.03% |
| Black Diamond Therapeutics Inc |
No change
131,990
|
$666,550,000 | 0.03% |
| iTeos Therapeutics, Inc. |
No change
45,735
|
$605,531,000 | 0.02% |
| Intercept Pharmaceuticals Inc |
No change
52,067
|
$575,861,000 | 0.02% |
| Universal Health Realty Income Trust |
No change
11,258
|
$535,656,000 | 0.02% |
| National Health Investors, Inc. |
No change
10,038
|
$526,192,000 | 0.02% |
| Beam Therapeutics Inc. |
No change
15,817
|
$505,037,000 | 0.02% |
| Tscan Therapeutics, Inc. |
No change
200,000
|
$500,000,000 | 0.02% |
| ALX Oncology Holdings Inc. |
No change
66,211
|
$497,245,000 | 0.02% |
| Community Healthcare Trust Inc |
No change
14,900
|
$491,998,000 | 0.02% |
| I-Mab |
No change
162,580
|
$486,114,000 | 0.02% |
| Biohaven Ltd |
Closed
35,087
|
$479,288,000 | |
| Novavax, Inc. |
No change
63,800
|
$474,034,000 | 0.02% |
| Hillevax, Inc. |
Opened
27,000
|
$464,130,000 | 0.02% |
| Sutro Biopharma Inc |
No change
98,354
|
$457,346,000 | 0.02% |
| Community Health Systems, Inc. |
No change
88,335
|
$388,674,000 | 0.02% |
| Affimed N.V. |
No change
586,038
|
$350,568,000 | 0.01% |
| Repare Therapeutics Inc. |
No change
29,150
|
$308,407,000 | 0.01% |
| Altimmune Inc |
No change
75,000
|
$264,750,000 | 0.01% |
| Fusion Pharmaceuticals Inc. |
No change
43,394
|
$203,084,000 | 0.01% |
| Codexis Inc. |
No change
69,125
|
$193,550,000 | 0.01% |
| Harpoon Therapeutics, Inc. |
No change
259,910
|
$184,536,000 | 0.01% |
| Precision BioSciences, Inc. |
No change
224,534
|
$118,105,000 | 0.00% |
| Spectrum Pharmaceuticals, Inc. |
No change
114,670
|
$110,083,000 | 0.00% |
| Adicet Bio, Inc. |
No change
40,329
|
$97,999,000 | 0.00% |
| Praxis Precision Medicines, Inc. |
No change
75,000
|
$86,250,000 | 0.00% |
| ARCA biopharma Inc |
No change
32,461
|
$65,896,000 | 0.00% |
| Nkarta, Inc. |
No change
28,988
|
$63,484,000 | 0.00% |
| Mallinckrodt Plc |
No change
35,048
|
$41,357,000 | 0.00% |
| Corbus Pharmaceuticals Holdings Inc |
No change
5,143
|
$40,321,000 | 0.00% |
| VYNE Therapeutics Inc. |
No change
7,520
|
$30,531,000 | 0.00% |
| Nexgel, Inc. |
No change
4,243
|
$10,650,000 | 0.00% |
| Bellicum Pharmaceuticals Inc |
No change
6,000
|
$2,220,000 | 0.00% |
| No transactions found | |||
| Showing first 500 out of 186 holdings | |||